PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

✍ Scribed by Ramachandran, S.; Mahabaleshwarkar, R.; Yang, Y.

• Book ID: 122320083
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 56 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.03.1305